Acergy S.A. (ADR) (NASDAQ: ACGY) up 2.2`% to $16.62 in pre-market trading. (NASDAQ: ACGY) (ACGY)
Orexigen Therapeutics Inc. (NASDAQ: OREX) up 21.13% to $5.56 in pre-market trading. The company entered into a partnership with Takeda to commercialize Contrave® in North America. (NADAQ: OREX) (OREX)
Cardiome Pharma Corp. (NASDAQ: CRME) up 13.09% to $7 in pre-market trading. The company announced that the IV formulation of BRINAVESS™ has been granted marketing approval in the European Union. (NASDAQ: CRME) (CRME)
Melco Crown Entertainment Ltd (NASDAQ: MPEL) up 3.84% to $4.06 in pre-market trading. (NASDAQ: MPEL) (MPEL)
Amtech Systems Inc. (NASDAQ: ASYS) up 3.15% to $14.72 in pre-market trading. The company’s subsidiary received new solar orders worth $37 million. (NASDAQ: ASYS) (ASYS)
- Want more? Check out the message board buzz for ACGY, OREX, CRME, MPEL, ASYS
- See what newsletters are recommending this stock here
- Get breaking news alerts on this stock: http://thestockmarketwatch.com/
- Need fast service and cheap rates from a broker? Buy stock online at my favorite brokerage
- See today’s top stock picks and market analysis
- Want more? Check out the message board buzz for these stocks
- See what newsletters are recommending these stock picks
- Get breaking news alerts on these stocks: http://thestockmarketwatch.com/
- This newsletter has been helping traders make a killing on these stocks. Click here for a 25% discount offer.
About BeaconEquity.com
BeaconEquity.com is committed to producing the highest-quality insight and analysis of small-cap stocks, emerging technology stocks, hot penny stocks and helping investors make informed decisions. Our focus is primarily OTC stocks in the stock market today, which have traditionally been shunned by Wall Street. We have particular expertise with renewable energy stocks, biotech stocks, oil stocks, green energy stocks and internet stocks. There are many hot penny stock opportunities present in the OTC market everyday and we seek to exploit these hot stock gains for our members before the average daytrader is aware of them.
Beacon Equity Group Disclaimer
This newsletter is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Beaconequity.com is a wholly-owned subsidiary of BlueWave Advisors.
While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.
